Biological functions of hCG and hCG-related molecules
- PMID: 20735820
- PMCID: PMC2936313
- DOI: 10.1186/1477-7827-8-102
Biological functions of hCG and hCG-related molecules
Abstract
Background: hCG is a term referring to 4 independent molecules, each produced by separate cells and each having completely separate functions. These are hCG produced by villous syncytiotrophoblast cells, hyperglycosylated hCG produced by cytotrophoblast cells, free beta-subunit made by multiple primary non-trophoblastic malignancies, and pituitary hCG made by the gonadotrope cells of the anterior pituitary.
Results and discussion: hCG has numerous functions. hCG promotes progesterone production by corpus luteal cells; promotes angiogenesis in uterine vasculature; promoted the fusion of cytotrophoblast cell and differentiation to make syncytiotrophoblast cells; causes the blockage of any immune or macrophage action by mother on foreign invading placental cells; causes uterine growth parallel to fetal growth; suppresses any myometrial contractions during the course of pregnancy; causes growth and differentiation of the umbilical cord; signals the endometrium about forthcoming implantation; acts on receptor in mother's brain causing hyperemesis gravidarum, and seemingly promotes growth of fetal organs during pregnancy. Hyperglycosylated hCG functions to promote growth of cytotrophoblast cells and invasion by these cells, as occurs in implantation of pregnancy, and growth and invasion by choriocarcinoma cells. hCG free beta-subunit is produced by numerous non-trophoblastic malignancies of different primaries. The detection of free beta-subunit in these malignancies is generally considered a sign of poor prognosis. The free beta-subunit blocks apoptosis in cancer cells and promotes the growth and malignancy of the cancer. Pituitary hCG is a sulfated variant of hCG produced at low levels during the menstrual cycle. Pituitary hCG seems to mimic luteinizing hormone actions during the menstrual cycle.
Figures


Similar articles
-
New discoveries on the biology and detection of human chorionic gonadotropin.Reprod Biol Endocrinol. 2009 Jan 26;7:8. doi: 10.1186/1477-7827-7-8. Reprod Biol Endocrinol. 2009. PMID: 19171054 Free PMC article. Review.
-
Physiology, Chorionic Gonadotropin.2022 Nov 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2022 Nov 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32310578 Free Books & Documents.
-
Hyperglycosylated hCG, a review.Placenta. 2010 Aug;31(8):653-64. doi: 10.1016/j.placenta.2010.06.005. Epub 2010 Jul 8. Placenta. 2010. PMID: 20619452 Review.
-
Human chorionic gonadotropin: Different glycoforms and biological activity depending on its source of production.Ann Endocrinol (Paris). 2016 Jun;77(2):75-81. doi: 10.1016/j.ando.2016.04.012. Epub 2016 May 10. Ann Endocrinol (Paris). 2016. PMID: 27177499 Review.
-
Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters.J Reprod Med. 2008 Jul;53(7):499-512. J Reprod Med. 2008. PMID: 18720925
Cited by
-
First-in-human trial assessing the pharmacokinetic-pharmacodynamic profile of a novel recombinant human chorionic gonadotropin in healthy women and men of reproductive age.Clin Transl Sci. 2021 Jul;14(4):1590-1599. doi: 10.1111/cts.13037. Epub 2021 Jun 21. Clin Transl Sci. 2021. PMID: 33982429 Free PMC article. Clinical Trial.
-
Risk of bronchopulmonary dysplasia by second-trimester maternal serum levels of α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.Pediatr Res. 2012 Apr;71(4 Pt 1):399-406. doi: 10.1038/pr.2011.73. Epub 2012 Feb 15. Pediatr Res. 2012. PMID: 22391642 Free PMC article.
-
S100P promotes trophoblast syncytialization during early placenta development by regulating YAP1.Front Endocrinol (Lausanne). 2022 Sep 14;13:860261. doi: 10.3389/fendo.2022.860261. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36187124 Free PMC article.
-
Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.Biomolecules. 2020 Jun 24;10(6):953. doi: 10.3390/biom10060953. Biomolecules. 2020. PMID: 32599856 Free PMC article. Review.
-
Extreme βHCG levels in first trimester screening are risk factors for adverse maternal and fetal outcomes.Sci Rep. 2023 Jan 21;13(1):1228. doi: 10.1038/s41598-023-28561-9. Sci Rep. 2023. PMID: 36681713 Free PMC article.
References
-
- Aschner B. Ueber die function der hypophyse. Pflug Arch Gest Physiol. 1912;146:1–147. doi: 10.1007/BF01681114. - DOI
-
- Fellner OO. Experimentelle untersuchungen uber die wirkung von gewebsextrakten aus der plazenta und den weiblichen sexualorganen auf das genital. Arch Gynakol. 1913;100:641. doi: 10.1007/BF01702558. - DOI
-
- Hirose T. Experimentalle histologische studie zur genese corpus luteum. Mitt Med Fakultd Univ ZU. 1919;23:63–70.
-
- Aschheim S, Zondek B. Das Hormon des hypophysenvorderlappens: testobjekt zum Nachweis des hormons. Klin Wochenschr. 1927;6:248–252. doi: 10.1007/BF01710709. - DOI
-
- Hoshina M, Boime I, Mochizuki M. Cytological localization of hPL, hCG, and mRNA in chorionic tissue using in situ hybridization. Acta Obstet Gynaecol Japonica. 1984;36:397–404. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources